1-2 of 2
Juan E. Arango Ossa
Close
Sort by
Journal Articles

Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

Clinical Trials & Observations
Daniel Leongamornlert, Jesús Gutiérrez-Abril, SooWah Lee, Emilio Barretta, Thomas Creasey, Gunes Gundem, Max F. Levine, Juan E. Arango-Ossa, Konstantinos Liosis, Juan S. Medina-Martinez, Krisztina Zuborne Alapi, Amy A. Kirkwood, Laura Clifton-Hadley, Pip Patrick, David Jones, Laura O’Neill, Adam P. Butler, Christine J. Harrison, Peter Campbell, Bela Patel, Anthony V. Moorman, Adele K. Fielding, Elli Papaemmanuil
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3862–3873.
https://doi.org/10.1182/bloodadvances.2022008992
Published: 2023
Includes: Supplemental data
Journal Articles

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Clinical Trials & Observations
John O. Mascarenhas, Raajit K. Rampal, Heidi E. Kosiorek, Rupali Bhave, Elizabeth Hexner, Eunice S. Wang, Aaron Gerds, Camille N. Abboud, Marina Kremyanskaya, Dimitry Berenzon, Olatoyosi Odenike, Noushin Farnoud, Aishwarya Krishnan, Rona Singer Weinberg, Erin McGovern, Mohamed E. Salama, Vesna Najfeld, Juan S. Medina-Martinez, Juan E. Arango Ossa, Max F. Levine, Yangyu Zhou, Lonette Sandy, Mark L. Heaney, Ross L. Levine, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5246–5256.
https://doi.org/10.1182/bloodadvances.2020002119
Published: 2020
Includes: Supplemental data